Skip to main content

Table 1 Baseline characteristics of the NSSIPL participants according to TyG-BMI levels

From: Estimate of prevalent ischemic stroke from triglyceride glucose-body mass index in the general population

Characteristics

Level of TyG-BMI

 

Low

(N = 3617)

Intermediated (N = 3628)

High

(N = 3617)

p value for liner trend

Age (years)

61.64 ± 10.82

59.63 ± 9.81

58.57 ± 9.26

< 0.001

Male [n (%)]

1768 (48.9)

1381 (38.1)

1215 (33.6)

< 0.01

Education [n (%)]

< 0.001

 Primary school or below

2209 (61.1)

2135 (58.8)

2080 (57.5)

 

 Middle school

1140 (31.5)

1165 (32.1)

1169 (32.3)

 

 High school or higher

268 (7.4)

328 (9.0)

368 (10.2)

 

Current smoking [n (%)]

1305 (36.1)

881 (24.3)

687 (19.0)

< 0.001

Current drinking [n (%)]

1188 (32.8)

969 (26.7)

900 (24.9)

< 0.001

Regular exercise [n (%)]

2979 (82.4)

3089 (85.1)

2997 (82.9)

0.569

SBP (mmHg)

139.50 ± 23.24

145.70 ± 22.47

151.88 ± 23.50

< 0.001

DBP (mmHg)

83.31 ± 11.57

86.45 ± 11.28

90.28 ± 11.88

< 0.001

FBG (mmol/L)

5.64 ± 1.16

6.06 ± 1.59

6.78 ± 2.42

< 0.001

TG (mmol/L)

0.98 ± 0.45

1.50 ± 0.89

2.48 ± 2.15

< 0.001

TC (mmol/L)

4.79 ± 0.98

5.14 ± 1.09

5.41 ± 1.20

< 0.001

LDL-C (mmol/L)

2.11 ± 0.80

2.37 ± 1.00

2.58 ± 1.18

< 0.001

HDL-C (mmol/L)

2.07 ± 0.61

1.94 ± 0.74

1.86 ± 0.88

< 0.001

Obesity/overweight [n (%)]

26 (0.7)

1542 (42.5)

3397 (93.9)

< 0.001

Hypertension [n (%)]

1757 (48.6)

2185 (60.2)

2636 (72.9)

< 0.001

Diabetes [n (%)]

217 (6.0)

508 (14.0)

1033 (28.6)

< 0.001

Dyslipidemia [n (%)]

422 (11.7)

998 (27.5)

1946 (53.8)

< 0.001

Atrial fibrillation [n (%)]

49 (1.4)

33 (0.9)

35 (1.0)

0.111

CHD [n (%)]

123 (3.4)

135 (3.7)

197 (5.4)

< 0.001

Ischemic stroke [n (%)]

159 (4.4)

194 (5.3)

243 (6.7)

< 0.001

  1. NSSIPL National Stroke Screening and Intervention Program in Liaoning, TyG-BMI triglyceride glucose-body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, FBG fasting blood glucose, TG triglycerides, TC total cholesterol, LDL-C low-density lipoprotein cholesterol, HDL-C high-density lipoprotein cholesterol, CHD coronary heart disease